Dynavax Technologies Logo

Dynavax Technologies

🇺🇸
DVAX
US2681582019

Dynavax Technologies is a leading US biotechnology company dedicated to developing and commercializing innovative vaccines and immunotherapies. Through its proprietary adjuvant technology, exemplified by HEPLISAV-B for Hepatitis B, the company provides protection against serious infectious diseases and improves global public health.

Next Quarterly Earnings

Tuesday, November 3, 2026
Expected

Stock Price

Frequently asked questions

When did Dynavax Technologies last report quarterly earnings?

Dynavax Technologies last reported quarterly earnings on 11/4/2025 (Q3 2025).

How do I add the Dynavax Technologies earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2025
Estimate:
Actual:

Company Information

Name
Dynavax Technologies
Ticker Symbol
DVAX
ISIN
US2681582019
Country
🇺🇸
USA
Sector